Literature DB >> 6949609

Acute promyelocytic leukaemia: a study of 39 cases with identification of a hyperbasophilic microgranular variant.

R W McKenna, J Parkin, C D Bloomfield, R D Sundberg, R D Brunning.   

Abstract

Thirty-nine cases of acute promyelocytic leukaemia (APL) were divided into two morphological subgroups, typical hypergranular APL (31 cases) and microgranular APL (eight cases, 21%). The leukaemic cells in the microgranular APL cases were characterized by striking nuclear folding or lobulation; granulation was present in most of these cells but was less abundant and finer than in typical APL. In three microgranular APL cases a distinctive small leukaemic promyelocyte with unusual nuclear lobulation and deeply basophilic cytoplasm containing few or no visable granules was the predominant leukaemic cell. This small hyperbasophilic promyelocyte was also present as a minor population of cells in the other five microgranular APL case and in 28 of the 31 typical APL cases. Ultrastructurally the most abundant promyelocytes in microgranular APL had smaller and usually fewer granules than in typical APL; other characteristic ultrastructural features of APL were found with equal frequency. The median blood leucocyte count was significantly higher in microgranular APL, 83.0 x 10(9) x 10(9)/l, than in typical APL, 1.8 x 10(9)/l (P less than 0.01). The median duration of complete remission (CR) for microgranular APL, 6.5 months, was shorter than the 21 + month median CR for typical APL. The morphological characteristics of microgranular APL may mimic those of myelomonocytic leukaemia; however, the presence of cells with multiple Auer rods, large inclusions of Auer-like material and the small hyperbasophilic promyelocytes are important distinguishing features. In equivocal cases cytochemistry, electron microscopy and cytogenetic studies may verify the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6949609     DOI: 10.1111/j.1365-2141.1982.tb01910.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Atypical features in a patient with acute promyelocytic leukaemia: a potential diagnostic pitfall.

Authors:  Muhajir Mohamed; Karen Dun; Julian Grabek
Journal:  BMJ Case Rep       Date:  2013-09-06

2.  A variant acute promyelocytic leukemia with t(11;17) (q23;q12); ZBTB16-RARA showing typical morphology of classical acute promyelocytic leukemia.

Authors:  Sang Bong Han; Jihyang Lim; Yonggoo Kim; Hee-Je Kim; Kyungja Han
Journal:  Korean J Hematol       Date:  2010-06-30

3.  Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.

Authors:  Martin S Tallman; Haesook T Kim; Pau Montesinos; Frederick R Appelbaum; Javier de la Serna; John M Bennett; Guillermo Deben; Clara D Bloomfield; Jose Gonzalez; James H Feusner; Marcos Gonzalez; Robert Gallagher; Jose D Gonzalez-San Miguel; Richard A Larson; Gustavo Milone; Elisabeth Paietta; Chelo Rayon; Jacob M Rowe; Concha Rivas; Charles A Schiffer; Edo Vellenga; Lois Shepherd; James L Slack; Peter H Wiernik; Cheryl L Willman; Miguel A Sanz
Journal:  Blood       Date:  2010-09-21       Impact factor: 22.113

Review 4.  Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.

Authors:  Guang-Biao Zhou; Ji Zhang; Zhen-Yi Wang; Sai-Juan Chen; Zhu Chen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

Review 5.  Acute Basophilic Leukemia: Recent Molecular and Diagnostic Update.

Authors:  Gyanendra Singh
Journal:  Cureus       Date:  2022-06-17

6.  LEUKAEMIC INVOLVEMENT OF CENTRAL NERVOUS SYSTEM.

Authors:  M Akhtar; A S Narayanaswamy; Rajat Kumar; S K Dham; J R Bhardwaj
Journal:  Med J Armed Forces India       Date:  2017-06-26

7.  Incidence of the 15q+;17q- chromosome translocation in acute promyelocytic leukaemia (APL).

Authors:  D Sheer; T A Lister; J Amess; E Solomon
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

8.  Acute Promyelocytic Leukemia: A Long-Term Retrospective Study in Mexico.

Authors:  Nidia Zapata-Canto; Manuel Aguilar; Luara Arana; Efren Montano; Cristian Ramos-Penafiel; Jose Antonio De la Pena; Jose Luis Alvarez-Vera; Eugenia Espitia-Rios; Juan Manuel Perez Zuniga; Eleazar Hernandez-Ruiz; Eduardo Cervera; Ramiro Espinoza-Zamora; Alejandro Sosa-Espinoza; Juan Carlos Solis-Poblano; Roberta Demichelis; David Gomez-Almaguer; Esperanza Barrera; Javier Mijangos; Ruben Solis-Armenta; Oscar de Jesus Perez; Miguel Herrera; Guillermo Diaz-Vargas; Alvaro Cabrera-Garcia; Juan Antonio Flores-Jimenez; Javier Morales-Adrian; Eva Fabiola Ramirez-Romero; Adrian Ceballos-Lopez; Victor Antonio Guillermo; Manuel Solano Manuel; Esthela Juan Lien-Chang Lourdes; Juan Ojeda-Tovar; Gladys Gomez-Perdomo; Martha Alvarado-Ibarra
Journal:  J Hematol       Date:  2021-04-27

9.  Early mortality in acute promyelocytic leukemia: Potential predictors.

Authors:  Can Chen; Xilian Huang; Kaile Wang; Kuang Chen; Danquan Gao; Shenxian Qian
Journal:  Oncol Lett       Date:  2018-01-24       Impact factor: 2.967

Review 10.  Therapeutic Approaches for Acute Promyelocytic Leukaemia: Moving Towards an Orally Chemotherapy-Free Era.

Authors:  Zheng-Li Xu; Xiao-Jun Huang
Journal:  Front Oncol       Date:  2020-10-20       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.